Herumb Pharmaceuticals And Chemical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 37 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -0.15%
- Profit Growth 7.71%
- Ebitda -5.88%
- Net Worth 8.46%
- Total Assets 18.88%
About Herumb Pharmaceuticals And Chemical
Herumb Pharmaceuticals And Chemical Private Limited (HPACPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 February 1987 and has a history of 37 years and 11 months. Its registered office is in Rajkot, Gujarat, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Jayesh Kamdar and Naresh Kamdar serve as directors at the Company.
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110GJ1987PTC009447
- Company No.
009447
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 1987
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Herumb Pharmaceuticals And Chemical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayesh Kamdar  | Managing Director | 16-Apr-2001 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naresh Kamdar | Director | 23-Apr-2019 | Current |
Financial Performance of Herumb Pharmaceuticals And Chemical.
Herumb Pharmaceuticals And Chemical Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 0.15% decrease. The company also saw a slight improvement in profitability, with a 7.71% increase in profit. The company's net worth moved up by a moderate rise of 8.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Herumb Pharmaceuticals And Chemical?
In 2017, Herumb Pharmaceuticals And Chemical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Herumb Pharmaceuticals And Chemical?
Unlock and access historical data on people associated with Herumb Pharmaceuticals And Chemical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Herumb Pharmaceuticals And Chemical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Herumb Pharmaceuticals And Chemical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
